Echo Therapeutics, Inc. Financing Interest Expense
Echo Therapeutics, Inc. reported Financing Interest Expense of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2016-11-16
- Echo Therapeutics, Inc. financing interest expense for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Echo Therapeutics, Inc. financing interest expense for the quarter ending 2016-06-30 was $0.00.
- Echo Therapeutics, Inc. financing interest expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Echo Therapeutics, Inc. financing interest expense for the quarter ending 2015-09-30 was $263.00K.
| Period end | Financing Interest Expense 3 month | Financing Interest Expense 6 month | Financing Interest Expense 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-16 | $0.00 derived: sum of 2 quarters · filed 2016-11-16 | $0.00 10-Q · filed 2016-11-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-20 | ||
| 2015-09-30 | $263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-16 | -$914.00K derived: sum of 2 quarters · filed 2016-11-16 | $4.62M 10-Q · filed 2016-11-16 |
| 2015-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $4.36M 10-Q · filed 2016-08-12 | |
| 2015-03-31 | $5.53M 10-Q · filed 2016-05-20 |